7539 related articles for article (PubMed ID: 2521335)
1. Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients.
Peng YM; Dalton WS; Alberts DS; Xu MJ; Lim H; Meyskens FL
Int J Cancer; 1989 Jan; 43(1):22-6. PubMed ID: 2521335
[TBL] [Abstract][Full Text] [Related]
2. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations.
Formelli F; Clerici M; Campa T; Di Mauro MG; Magni A; Mascotti G; Moglia D; De Palo G; Costa A; Veronesi U
J Clin Oncol; 1993 Oct; 11(10):2036-42. PubMed ID: 8410127
[TBL] [Abstract][Full Text] [Related]
3. Effects of N-(4-hydroxyphenyl)retinamide supplementation on vitamin A metabolism.
Lewis KC; Zech LA; Phang JM
Cancer Res; 1994 Aug; 54(15):4112-7. PubMed ID: 8033144
[TBL] [Abstract][Full Text] [Related]
4. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
Sani BP; Shealy YF; Hill DL
Carcinogenesis; 1995 Oct; 16(10):2531-4. PubMed ID: 7586162
[TBL] [Abstract][Full Text] [Related]
5. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
[TBL] [Abstract][Full Text] [Related]
6. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
[TBL] [Abstract][Full Text] [Related]
7. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
Smith JE; Lawless DC; Green MH; Moon RC
J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
[TBL] [Abstract][Full Text] [Related]
8. In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences.
Berni R; Formelli F
FEBS Lett; 1992 Aug; 308(1):43-5. PubMed ID: 1386578
[TBL] [Abstract][Full Text] [Related]
9. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM
Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611
[TBL] [Abstract][Full Text] [Related]
10. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Lewis KC; Hochadel JF
Cancer Res; 1999 Dec; 59(23):5947-55. PubMed ID: 10606240
[TBL] [Abstract][Full Text] [Related]
11. The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.
Hail N; Chen P; Wempe MF
Free Radic Biol Med; 2010 Dec; 49(12):2001-9. PubMed ID: 20923701
[TBL] [Abstract][Full Text] [Related]
12. Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients.
Formelli F; Cavadini E; Luksch R; Garaventa A; Appierto V; Persiani S
Cancer Chemother Pharmacol; 2010 Oct; 66(5):993-8. PubMed ID: 20532509
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.
Garaventa A; Luksch R; Lo Piccolo MS; Cavadini E; Montaldo PG; Pizzitola MR; Boni L; Ponzoni M; Decensi A; De Bernardi B; Bellani FF; Formelli F
Clin Cancer Res; 2003 Jun; 9(6):2032-9. PubMed ID: 12796365
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting plasma retinol decline during long-term administration of the synthetic retinoid fenretinide in breast cancer patients.
Torrisi R; Parodi S; Fontana V; Rondanina G; Formelli F; Costa A; Boccardo F; Decensi A
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):507-10. PubMed ID: 8000302
[TBL] [Abstract][Full Text] [Related]
15. [Effects of N-(4-hydroxyphenyl) retinamide lipid microbubble combined with ultrasound on human keloid fibroblasts].
Wang MJ; Fang YH; Jin CL; Jin ZH
Zhonghua Shao Shang Za Zhi; 2018 Oct; 34(10):683-689. PubMed ID: 30369135
[No Abstract] [Full Text] [Related]
16. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol.
Berni R; Clerici M; Malpeli G; Cleris L; Formelli F
FASEB J; 1993 Sep; 7(12):1179-84. PubMed ID: 8375617
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-(4-hydroxyphenyl)retinamide on vitamin A metabolism in rats.
Adams WR; Smith JE; Green MH
Proc Soc Exp Biol Med; 1995 Feb; 208(2):178-85. PubMed ID: 7831350
[TBL] [Abstract][Full Text] [Related]
18. N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats.
Schaffer EM; Ritter SJ; Smith JE
J Nutr; 1993 Sep; 123(9):1497-503. PubMed ID: 8360775
[TBL] [Abstract][Full Text] [Related]
19. Human plasma all-trans-, 13-cis- and 13-cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels.
Eckhoff C; Collins MD; Nau H
J Nutr; 1991 Jul; 121(7):1016-25. PubMed ID: 2051220
[TBL] [Abstract][Full Text] [Related]
20. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]